A new regulation by the CDSCO mandates that exported drugs must have at least 60% shelf life remaining, causing significant losses to the I...

The health ministry is considering strict actions, including immediate license suspensions, for drugmakers producing substandard drugs. Thi...

An Indian pharmaceutical company, Kusum Healthcare, operating in Ukraine, suffered significant damages after a warehouse was reportedly str...

Pharma lobby group FOPE has requested the government to extend the compliance deadline for the revised Schedule M till December 31, 2026. T...

Drugmakers in India may soon face stricter enforcement of quality standards. The revised Schedule M, which details manufacturing practices ...

Schedule M of the Drugs and Cosmetics Rules, 1945 prescribes the good manufacturing practices (GMP) for pharmaceutical products, such as a ...

In a significant development, a five-member expert committee has been appointed to assess the feasibility of allowing the manufacturing of ...

The government has expanded a committee to include more industry representation for reviewing drug and medical device pricing reforms. This...

In a recent diktat, the government said action will be taken against pharma units that are flouting the norms by manufacturing nutraceutica...

The government, DCGI, and state authorities are cracking down on pharma units manufacturing nutraceuticals, health supplements, and drugs i...

FOPE said that the manufactures follow the rules as laid down in the DPCO, 2013. At the same time, manufacturers look to NPPA to fix the pr...

Representatives of several small and medium pharma companies have suggested that the government adopt a "one molecule-one MRP" formula inst...

The high court, while lifting the ban on 344 drugs, had pulled up the government for haphazardly banning the drugs.

The HC asked the government whether it needed to consider the validity of licences held by pharma companies producing the combination drugs...

Terming the decision to ban 344 fixed dose combination medicines as "arbitrary and unfair", pharma industry has said it feels let down by t...

The excise duty incentives announced in this year’s budget may have been welcomed by the industry, but it has spelt doom for excise free zo...

The Andhra Pradesh government along with the Federation of Asian Biotech Associations (FABA), the University of Hyderabad and the European ...